CP-744809 is a highly selective orally bioavailable small molecule inhibitor of aldose reductase. References: Sun W, Oates PJ, Coutcher JB, Gerhardinger C, Lorenzi M. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy. Diabetes. 2006 Oct;55(10):2757-62. PubMed PMID: 17003340.

纯度：≥98%

CAS：463976-07-0